Page 2 - Scientific Library

tebu-bio signed recently a distribution agreement with HemaCare Corp. Built on a 36-year history in apheresis collection, HemaCare is a leader in cell and tissue collection and processing, providing high-quality

RNA-based CRISPR-CAS9 gene editing is a vector-free approach that is required for therapeutic perspectives. However, from a practical point of view, what appears as a major challenge to engineer primary

Over the years, people have started to understand the need for science to get materials to learn and progress. Materials include not only medical tools, but also biological ones.

Many people still ignore